Pembrolizumab + chemotherapy beneficial in advanced NSCLC, even without PD-L1 expression

Trial

KEYNOTE-021, KEYNOTE-189, KEYNOTE 407

Conference

WCLC 2019

8 November, 2019 22:57

Next generation immunotherapy in non-small-cell lung cancer

Presented By

Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland

Conference

WCLC 2018

21 November, 2018 23:02

Presented By

Prof. Martin Reck, German Center for Lung Research, Germany

Conference

WCLC 2018

21 November, 2018 22:05

Presented By

Prof. Balazs Halmos, Albert Einstein College of Medicine and Montefiore Medical Center, USA

Trial

Phase 3, KEYNOTE-407

Conference

WCLC 2018

21 November, 2018 21:18